Trial Profile
An Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every Twelve Hours for Two Weeks in Subjects With Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2023
Price :
$35
*
At a glance
- Drugs Clascoterone (Primary)
- Indications Acne vulgaris
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Intrepid Therapeutics
- 29 May 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 12 May 2014 New trial record